Startups

Quantum simulation platform for drug discovery.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 23,000 COMPANIES →

Summary

Seedtable Score

Score icon 68

Locations

Company Size

  • 1 - 11

Last Stage Round

Insights

Kuano, based in London, offers a quantum simulation platform aimed at transforming drug discovery for biotech and health tech companies. Their B2B, SaaS model provides faster and more accurate simulations compared to traditional methods, potentially reducing timelines and costs. Supported by investors like Ascension Ventures and ACF Investors, Kuano leverages quantum computing to offer a competitive edge in a market dominated by longer, costlier processes. If successful, Kuano could significantly impact the development of new drugs.

Total Funding
$2.2M

Investors

Full Company Profile